16th Edition Partnerships & Portfolio Optimization for Accessible Medicines and Generics 2024 | Marcus Evans Group | 18 September 2024 | TBA, Morristown, NJ
Venue
TBA
TBA, Morristown, NJ
What is Qwoted?
Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.
| Event Date | Wed Sep 18 EDT - Thu Sep 19 EDT (8 months ago) |
| Location |
TBA
Morristown, NJ |
| Region | Americas |
Details
In order to sustain a competitive advantage the manufacturers of generic drugs, biologics, biosimilars and non-branded drugs need to innovate their business models, deal structures and organizations with new ways to research, develop, formulate, commercialize and sell their products. Attending this premier marcus evans conference will permit attendees the chance to review successful alliances, innovation, partnerships, M&A activity, and portfolios at the right size, price, and mix of complexity to sustain value optimization in a domestic and international market.
Key Sessions:
• Orchestrating Portfolio Management within the Ever Changing Legal and Regulatory Environment
• Illustrating the Path to Success for Accessible Medicines, Generic Drugs and Portfolio Diversification
• Analyzing Biosimilars in an Evolving Policy Landscape
• Unpacking Strategies and Lessons Learned from ANDAs and 505b2s
• Reviewing the Pros and Cons of Make versus Buy
• Recalibrating Portfolio Management to account for More Complex Generics and Biologics
Speakers
2024 Speakers
Stephen Beckman
CEO, Yaral Pharma
Nicole L. Duff DeSantis
Founder / Principal, PuzzlePharm
Nailesh Bhatt
CEO, VGYAAN Pharmaceuticals
Rajesh Desikan
Vice President & Head, US Marketing & Commercial Operations Excellence, Oncology & Immunology, Fresenius Kabi
Maha Mehanna
Vice President, Business Development & Portfolio, XGen Pharmaceuticals DJB
Amit Kumar
Head of Corporate PMO, American Regent (Daiichi Sankyo Company)
Smiti Kumar
Head, Strategic Portfolio Management, North America, Dr. Reddy's Laboratories
Sandeep Kumar
Formerly Director, Product Development, R&D, Previously with SUN PHARMA
Malcolm Rosenthal
Sr. Director Business Development, Escientia Life Sciences
Nikhila Shashikanth
Director Business Development & Operations, Spring Bio Solution
Mahendra Gunjal
Senior Manager, Portfolio Management, Azurity Pharmaceuticals